Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Publication year range
1.
Arq Neuropsiquiatr ; 77(6): 381-386, 2019 07 15.
Article in English | MEDLINE | ID: mdl-31314839

ABSTRACT

OBJECTIVE: To investigate the expressions of plasma cystatin C (Cys-C), D-dimer (D-D) and hypersensitive C-reactive protein (hs-CRP) in patients with intracranial progressive hemorrhagic injury (IPHI) after craniocerebral injury, and their clinical significance. METHODS: Forty-two IPHI patients and 20 healthy participants (control) were enrolled. The severity and outcome of IPHI were determined according to the Glasgow Coma Scale and Glasgow Outcome Scale, and the plasma Cys-C, hs-CRP and D-D levels were measured. RESULTS: The plasma Cys-C, D-D and hs-CRP levels in the IPHI group were significantly higher than those in the control group (p < 0.01). There were significant differences of plasma Cys-C, D-D and hs-CRP levels among different IPHI patients according to the Glasgow Coma Scale and according to the Glasgow Outcome Scale (all p < 0.05). In the IPHI patients, the plasma Cys-C, D-D and hs-CRP levels were positively correlated with each other (p < 0.001). CONCLUSION: The increase of plasma Cys-C, D-D and hs-CRP levels may be involved in IPHI after craniocerebral injury. The early detection of these indexes may help to understand the severity and outcome of IPHI.


Subject(s)
C-Reactive Protein/analysis , Cystatin C/blood , Fibrin Fibrinogen Degradation Products/analysis , Intracranial Hemorrhage, Traumatic/blood , Adolescent , Adult , Case-Control Studies , Child , Female , Glasgow Outcome Scale , Humans , Intracranial Hemorrhage, Traumatic/physiopathology , Male , Middle Aged , Reference Values , Risk Factors , Trauma Severity Indices , Young Adult
2.
Arq. neuropsiquiatr ; Arq. neuropsiquiatr;77(6): 381-386, June 2019. tab
Article in English | LILACS | ID: biblio-1011358

ABSTRACT

ABSTRACT Objective To investigate the expressions of plasma cystatin C (Cys-C), D-dimer (D-D) and hypersensitive C-reactive protein (hs-CRP) in patients with intracranial progressive hemorrhagic injury (IPHI) after craniocerebral injury, and their clinical significance. Methods Forty-two IPHI patients and 20 healthy participants (control) were enrolled. The severity and outcome of IPHI were determined according to the Glasgow Coma Scale and Glasgow Outcome Scale, and the plasma Cys-C, hs-CRP and D-D levels were measured. Results The plasma Cys-C, D-D and hs-CRP levels in the IPHI group were significantly higher than those in the control group (p < 0.01). There were significant differences of plasma Cys-C, D-D and hs-CRP levels among different IPHI patients according to the Glasgow Coma Scale and according to the Glasgow Outcome Scale (all p < 0.05). In the IPHI patients, the plasma Cys-C, D-D and hs-CRP levels were positively correlated with each other (p < 0.001). Conclusion The increase of plasma Cys-C, D-D and hs-CRP levels may be involved in IPHI after craniocerebral injury. The early detection of these indexes may help to understand the severity and outcome of IPHI.


RESUMO Objetivo Investigar as expressões da cistatina C plasmática (Cys-C), dímero-D (D-D) e proteína C-reativa hipersensível (hs-CRP) em pacientes com lesão hemorrágica progressiva intracraniana (IPHI) após lesão craniocerebral e seus significados clínicos. Métodos Quarenta e dois pacientes com IPHI e 20 indivíduos saudáveis (controle) foram incluídos. A gravidade e o resultado do IPHI foram determinados de acordo com a Escala de Coma de Glasgow (GCS) e Escala de Resultados de Glasgow (GOS), e os níveis plasmáticos Cys-C, hs-CRP e D-D foram detectados. Resultados Os níveis plasmáticos de Cys-C, D-D e hs-CRP no grupo IPHI foram significativamente maiores do que no grupo controle (P <0,01). Houve diferença significativa entre os níveis plasmáticos de Cys-C, D-D e hs-CRP entre os diferentes pacientes com IPHI de acordo com a GCS e entre os diferentes pacientes com IPHI de acordo com o GOS, respectivamente (todos P <0,05). Em pacientes com IPHI, os níveis plasmáticos de Cys-C, D-D e hs-CRP foram positivamente correlacionados entre si (P <0,001). Conclusão O aumento dos níveis plasmáticos de Cys-C, D-D e hs-CRP pode estar envolvido no IPHI após trauma crânio-encefálico. A detecção precoce desses índices pode ajudar a entender a gravidade e o resultado do IPHI.


Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Young Adult , C-Reactive Protein/analysis , Fibrin Fibrinogen Degradation Products/analysis , Intracranial Hemorrhage, Traumatic/blood , Cystatin C/blood , Reference Values , Case-Control Studies , Trauma Severity Indices , Risk Factors , Intracranial Hemorrhage, Traumatic/physiopathology , Glasgow Outcome Scale
3.
J. bras. med ; 94(6): 32-35, jun. 2008. ilus
Article in Portuguese | LILACS | ID: lil-532648

ABSTRACT

O traumatismo craniencefálico pode resultar em lesões intracranianas difusas ou focais, representando afecções traumatoógicas graves, em parte necessitando de atendimento e conduta neurocirúrgica de emergência. As principais lesões focais de indicação cirúrgica são os hematomas epidurais, os hematomas subdurais agudos e as contusões cerebrais. Há ainda controvérsias sobre o tratamento em muitas situações. Os autores realizaram revisão da literatura descrevendo os princípios do tratamento cirúrgico de lesões focais secundárias ao trauma de crânio.


Head trauma presents in some cases, intracranial lesions, diffuse and focal. The more important lesions are acute epidural hematoma, subdural hematoma and brain contusions. There is controversy about the surgical treatment. In this study, the authors describe a critical review of literature about principles for surgical management for focal lesions by head trauma.


Subject(s)
Humans , Male , Female , Intracranial Hemorrhage, Traumatic/surgery , Intracranial Hemorrhage, Traumatic/physiopathology , Craniocerebral Trauma/surgery , Cerebral Angiography , Hematoma, Epidural, Cranial/surgery , Hematoma, Epidural, Cranial/therapy , Hematoma, Subdural/surgery , Hematoma, Subdural/therapy
SELECTION OF CITATIONS
SEARCH DETAIL